2
Chronic renal disease and antenatal care

https://doi.org/10.1016/j.bpobgyn.2018.10.002Get rights and content

Highlights

  • Maternal and foetal outcomes for women with CKD have markedly improved.

  • Pre-pregnancy counselling is crucial in preparing for women with CKD for pregnancy. Multidisciplinary team care is critical for a positive patient experience.

  • Medication management includes discontinuation of potentially teratogenic treatments well in advance of a planned pregnancy, notably mycophenolate.

  • Enhanced monitoring during pregnancy is required for women with all stages of CKD.

  • Pregnant women receiving dialysis and transplant recipients need specialist care.

Abstract

In 2018, it is unusual for women with chronic kidney disease (CKD) to be told that pregnancy is not an option. Maternal and foetal outcomes have steadily improved over the last 50 years and a successful pregnancy, resulting in a healthy infant without detrimental to maternal health, is commonplace. Nevertheless, the incidence of adverse outcomes including pre-eclampsia, preterm birth and small-for-gestational age infants is higher for women with CKD than the general population, requiring enhanced monitoring. Furthermore, as women with more advanced renal disease including dialysis recipients are supported in contemplating pregnancy, the importance of an experienced multidisciplinary team (MDT) has become crucial. Pre-pregnancy planning underpins optimisation of pregnancy outcomes.

Introduction

The decision to start a family can be accompanied by a sense of apprehension and this is particularly true for patients with chronic medical conditions. For women with chronic kidney disease (CKD), concerns over the impact of pregnancy on their own health, and CKD on a pregnancy, can accentuate their anxiety.

There have been marked improvements in pregnancy outcomes for women with CKD over the last 50 years, meaning that it is unusual to recommend that women with CKD avoid becoming pregnant (Fig. 1) [1]. Nevertheless, risks of adverse maternal and infant outcomes are higher than in the general population, across the spectrum of severity of renal disease. Pre-pregnancy counselling and additional antenatal care are indicated to optimise outcomes.

Section snippets

Defining chronic kidney disease

CKD is defined as decreased excretory renal function, haematuria or proteinuria persisting for more than 3 months, anatomical abnormalities (such as reflux nephropathy or renal dysgenesis), or genetic variants associated with renal disease (such as Alport syndrome or polycystic kidney disease). Outside of pregnancy, severity of CKD can be staged based on estimated glomerular filtration rate (GFR) and urine albumin excretion rate, usually quantified by a urine albumin:creatinine ratio (uACR).

Pre-pregnancy counselling

Consensus statements published in 2018 recommend that women with CKD should be offered pre-pregnancy counselling by a MDT including an obstetrician, renal/obstetric physician and a specialist midwife [4]. Counselling is not always possible because pregnancy may not be a planned event; however, the aims of pre-pregnancy counselling are to:

  • discuss optimal timing for a planned pregnancy

  • assess and optimise disease stability

  • change agents that are not safe or ideal for use in pregnancy

  • outline the

Antenatal care

Confirmation of successful pregnancy is usually straightforward in women with CKD and preserved renal function. For women with advanced CKD, including those requiring dialysis, serum beta-human chorionic gonadotrophin (β-HCG) levels are elevated as compared to healthy controls at equivalent gestational age due to diminished urinary clearance [54], [55]. This is of clinical significance when a serum β-HCG suggesting 8 weeks gestation is not confirmed by an identified foetal heart rate on

Dialysis and pregnancy

It is rare for patients receiving dialysis to become pregnant because of patient choice, impaired fertility (see Fig. 2) and reduced libido [65]. There are less than 200 pregnancies reported worldwide in women receiving peritoneal dialysis [66], however, the possibility of pregnancy with haemodialysis is no longer inconceivable.

For most women receiving dialysis, the best chance of a successful pregnancy would follow successful renal transplantation. If this is not feasible (due to urological

Renal transplantation and pregnancy

The general principles of managing pregnancy in a renal transplant recipient are the same as for any women with CKD – close attention to fluid status, blood pressure, proteinuria and foetal growth with optimisation of timing of delivery.

Standard care should be supplemented by consideration of the following:

Conflicts of interest

Nil.

Acknowledgements

This work was supported by a grant from Nottingham Hospitals Charity.

References (75)

  • A.L. Tranquilli et al.

    The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP

    Pregnancy Hypertens

    (2014 Apr)
  • K. Bramham et al.

    Diagnostic and predictive biomarkers for pre-eclampsia in patients with established hypertension and chronic kidney disease

    Kidney Int

    (2016 Apr)
  • B.G. Fahy et al.

    Pregnancy tests with end-stage renal disease

    J Clin Anesth

    (2008 Dec)
  • K. Higby et al.

    Normal values of urinary albumin and total protein excretion during pregnancy

    Am J Obstet Gynecol

    (1994)
  • M.T. Filocamo et al.

    Sexual dysfunction in women during dialysis and after renal transplantation

    J Sex Med

    (2009 Nov)
  • I. Okundaye et al.

    Registry of pregnancy in dialysis patients

    Am J Kidney Dis

    (1998 May)
  • A.I. Katz et al.

    Pregnancy in women with kidney disease

    Kidney Int

    (1980 Aug)
  • E. Imbasciati et al.

    Pregnancy in CKD stages 3 to 5: fetal and maternal outcomes

    Am J Kidney Dis

    (2007 Jun)
  • M.C. Smith et al.

    Assessment of glomerular filtration rate during pregnancy using the MDRD formula

    BJOG

    (2008 Jan)
  • A.B. Alper et al.

    Performance of estimated glomerular filtration rate prediction equations in preeclamptic patients

    Am J Perinatol

    (2011 June 01)
  • M. Hall et al.

    Consensus statements 2017

  • K.S. Wiles et al.

    Pre-pregnancy counselling for women with chronic kidney disease: a retrospective analysis of nine years' experience

    BMC Nephrol

    (2015 Mar 14)
  • V.S. Lim et al.

    Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation

    Ann Intern Med

    (1980 July 01)
  • C.T. Lin et al.

    Menstrual disturbances in premenopausal women with end-stage renal disease: a cross-sectional study

    Med Princ Pract

    (2016)
  • E. Sikora-Grabka et al.

    Serum anti-Mullerian hormone concentration in young women with chronic kidney disease on hemodialysis, and after successful kidney transplantation

    Kidney Blood Press Res

    (2016)
  • I. Szydlowska et al.

    Assessment of ovarian reserve as an indicator of fertility and health consequences in patients with chronic kidney disease stages 3-4

    Gynecol Endocrinol

    (2018 June 19)
  • M. Hoeltzenbein et al.

    Teratogenicity of mycophenolate confirmed in a prospective study of the European network of teratology information services

    Am J Med Genet A

    (2012 Mar)
  • I.F. Tjeertes et al.

    Neonatal anemia and hydrops fetalis after maternal mycophenolate mofetil use

    J Perinatol

    (2007 Jan)
  • B.F. Palmer et al.

    Gonadal dysfunction in chronic kidney disease

    Rev Endocr Metab Disord

    (2017 Mar)
  • European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.10. Pregnancy in renal transplant recipients

    Nephrol Dial Transplant

    (2002)
  • N.M. Sifontis et al.

    Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus

    Transplantation

    (2006 Dec 27)
  • D. Williams et al.

    Chronic kidney disease in pregnancy

    BMJ

    (2008 Jan 26)
  • K.S. Wiles et al.

    Reproductive health and pregnancy in women with chronic kidney disease

    Nat Rev Nephrol

    (2018 March 01)
  • KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease

    Kidney Int Suppl

    (2012)
  • J.T. Wright et al.

    A randomized trial of intensive versus standard blood-pressure control

    N Engl J Med

    (2015 November 26)
  • L.A. Magee et al.

    Less-tight versus tight control of hypertension in pregnancy

    N Engl J Med

    (2015 Jan 29)
  • Hypertension in pregnancy: diagnosis and management

    (2010)
  • Cited by (7)

    • Associations between inpatient psychiatric admissions during pregnancy and adverse obstetrical and birth outcomes

      2021, American Journal of Obstetrics and Gynecology MFM
      Citation Excerpt :

      Thus, the attentive inpatient care by a multidisciplinary team that included obstetricians, midwives, maternal-fetal medicine specialists, psychiatrists, psychologists, social workers, nurses, occupational therapists, and ethics committee members11,13 may be the mechanism through which benefit to the health of the mother and her future child is conferred. For patients with chronic medical conditions, coordinated, interdisciplinary care is the backbone for safe and successful pregnancies34,35 and our findings with respect to psychiatric conditions can be understood similarly. Furthermore, although admission to an inpatient psychiatric ward is commonly viewed as a tool for acute stabilization with the goal of discharge as soon as possible, some providers propose longer stays with an aim to not only acutely stabilize patients with psychiatric illness but also to prepare the patient for a path that will allow them to succeed outside of the inpatient unit.36

    • Chronic kidney disease in pregnant women

      2021, Revista Colombiana de Nefrologia
    View all citing articles on Scopus
    View full text